PMID: 7046699Mar 1, 1982Paper

Evaluation of flurazepam and placebo on sleep disorders in childhood

Arquivos de neuro-psiquiatria
R N Reimão, A B Lefévre


The clinically observed results in 40 patients, from 1 to 15 years old, presenting sleep disturbances, in a comparative and statistically approached study of flurazepam 15mg daily against placebo, are reported. Placebo was administered, followed by the drug, during 14 days each. The chief complaints were sleepwalking, sleep-talking, sleep terror, sleep-related bruxism, sleep-related headbanging, insomnia and excessive movements during sleep. A significant effect of flurazepam on sleepwalking, sleep-talking, bruxism, sleep terror and excessive movement during sleep, was observed. The insomniac headbanging patients were not enough for statistical analysis. Flurazepam side effects were excessive drowsiness during daytime in 3 cases; irritability, 3 cases; nausea and vomiting, 2 cases, and were not correlated with age. Placebo side effects were similar, except for nausea and vomiting which were not observed. It was necessary to discontinue flurazepam in 2 cases, because of excessive drowsiness during daytime, which did not improve when reducing the dose.


May 1, 1976·Clinical Pharmacology and Therapeutics·A KALESJ D Kales
Jan 1, 1978·The Journal of International Medical Research·A J Bowen
Apr 5, 1979·The New England Journal of Medicine·F SolomonWallace B Mendelson
Mar 28, 1979·Psychopharmacology·M W Church, L C Johnson
Jan 1, 1976·Electroencephalography and Clinical Neurophysiology·L C JohnsonR G Bickford
Sep 1, 1979·Electroencephalography and Clinical Neurophysiology·L C JohnsonM Sinclair
Jan 1, 1975·Journal of the American Academy of Child Psychiatry·P R Keith
Jan 1, 1975·Clinical Pharmacology and Therapeutics·D J GreenblattJ Koch-Weser
Sep 1, 1975·Clinical Pharmacology and Therapeutics·A KALESM B Scharf
Nov 1, 1979·The American Journal of Psychiatry·M R FreidinW D Singer
Jul 1, 1975·The American Journal of Psychiatry·H H Comly
Jan 24, 1976·British Medical Journal·K AdamI Oswald
Dec 1, 1972·Electroencephalography and Clinical Neurophysiology·C A TassinariH Gastaut
Aug 30, 1969·Nature·I Oswald
Sep 1, 1970·Archives of General Psychiatry·A KALESJ D Kales
Oct 1, 1970·Journal of the American Psychoanalytic Association·C FisherE Kahn
Jul 1, 1971·Clinical Pharmacology and Therapeutics·J D KalesE S Slye
Feb 28, 1974·The New England Journal of Medicine·A KALES, J D Kales
Dec 7, 1972·The New England Journal of Medicine·L Lasagna
Sep 28, 1973·Psychopharmacologia·A J Bond, M H Lader
Dec 1, 1971·The American Journal of Psychiatry·R B Pesikoff, P C Davis
Sep 1, 1968·Journal of Dental Research·G R REDINGV H Smith
Dec 1, 1968·International Journal of Orthodontics·G R REDINGV H Smith
Aug 1, 1966·The Journal of Nervous and Mental Disease·A M Arkin
Jan 1, 1968·Psychopharmacologia·E Hartmann
Jan 1, 1980·Brain & Development·R N Reimão, A B Lefévre
Jul 1, 1954·Neurology·B FUSTERM ETCHEVERRY
Aug 1, 1958·Pediatric Clinics of North America·H F SHIRLEY, J P KAHN
Jun 1, 1961·Journal of Child Psychology and Psychiatry, and Allied Disciplines·J EVANS
Dec 1, 1962·Archives of General Psychiatry·A RECHTSCHAFFENA SHAPIRO
Aug 14, 1964·Science·G R REDINGR S DANIELS
May 14, 1965·Science·A JACOBSONJ R ZWEIZIG


Feb 8, 2011·Research in Developmental Disabilities·Jill A Hollway, Michael G Aman
Sep 27, 2005·The Journal of Pediatrics·Tamar EtzioniGiora Pillar
Mar 9, 2010·Thérapie·Claire ChevreuilGroupe d'Etude Interdisiplinaire de Bretagne Psychotropes chez l'enfant et l'adolescent
Oct 6, 2004·Expert Opinion on Pharmacotherapy·Agnes Remulla, Christian Guilleminault
Jan 1, 1992·Journal of Child Psychology and Psychiatry, and Allied Disciplines·K D Gadow
Feb 27, 2019·Cranio : the Journal of Craniomandibular Practice·Gaetano IerardoAntonella Polimeni
Mar 1, 1989·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·J G Simeon
Dec 21, 2019·European Journal of Pediatrics·Luiz Alexandre ChisiniMarília Leão Goettems

Related Concepts

Clinical Trials
Subwakefullness Syndrome

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.